|
Title:
|
Efficacy and Safety of Surufatinib in Patients with Well-Differentiated Advanced Extrapancreatic Neuroendocrine Tumors: Results from the Randomized Phase III Study (SANET-ep) |
| Presenting Author: | Jianming Xu, Head of the Department of Gastrointestinal Oncology, The Fifth Medical Center, General Hospital of the PLA |
| Abstract #: | LBA76 |
| Date & Time: | Sunday, September 29, 2019, 16:30 CEST |
| Location: | Tarragona Auditorium (Hall 7), Fira de Barcelona Gran Via Conference Centre |